{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:20:59Z","timestamp":1794370859503,"version":"4.9.0"},"edition-number":"1","reference-count":65,"publisher":"Cambridge University Press","isbn-type":[{"value":"9780521515030","type":"print"},{"value":"9780511551901","type":"electronic"}],"license":[{"start":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T00:00:00Z","timestamp":1247270400000},"content-version":"unspecified","delay-in-days":257,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,27]]},"DOI":"10.1017\/cbo9780511551901.009","type":"book-chapter","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T09:31:08Z","timestamp":1261647068000},"page":"101-111","source":"Crossref","is-referenced-by-count":0,"title":["ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA"],"prefix":"10.1017","author":[{"given":"William I.","family":"Bensinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","reference":[{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib666","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704531"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib682","doi-asserted-by":"crossref","first-page":"1021a","DOI":"10.1182\/blood.V108.11.3575.3575","article-title":"A phase 1 dose escalation study of a fully human antagonist anti-CD40 antibody, HCD122 (formerly CHIR-12.12) in patients with relapsed and refractory multiple myeloma [abstract]","volume":"108","author":"Bensinger","year":"2006","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib640","first-page":"635a","article-title":"Allografts after reduced intensity conditioning can induce long-term remission in patients with chemosensitive relapsed multiple myeloma (MM)","volume":"100","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib656","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04299.x"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib659","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0131"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib672","doi-asserted-by":"crossref","first-page":"149a","DOI":"10.1182\/blood.V110.11.482.482","article-title":"An update on a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma [abstract]","volume":"110","author":"Bruno","year":"2007","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib629","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90871-5"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib677","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403698"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib660","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1150"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib643","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809068567"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib673","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101183440303"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib684","doi-asserted-by":"crossref","first-page":"723a","DOI":"10.1182\/blood.V106.11.2572.2572","article-title":"A phase I humanized anti-CD40 monoclonal antibody (SGN-40) in patients with multiple myeloma [abstract]","volume":"106","author":"Hussein","year":"2005","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib664","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","article-title":"Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities","volume":"95","author":"Desikan","year":"2000","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib686","first-page":"77","article-title":"Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma","volume":"10","author":"Ma","year":"2004","journal-title":"Hong Kong Med J"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib630","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64525-4"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib650","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3390"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib683","doi-asserted-by":"crossref","first-page":"986a","DOI":"10.1182\/blood.V108.11.3457.3457","article-title":"a potential new therapeutic target for the treatment of multiple myeloma [abstract]","volume":"108","author":"Hsi","year":"2006","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib680","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0527"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib670","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4435"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib690","doi-asserted-by":"crossref","first-page":"224a","DOI":"10.1182\/blood.V110.11.729.729","article-title":"Tandem autologous transplant versus reduced intensity conditioned allogeneic transplant (allo-RIC) as second intensification in chemosensitive patients with multiple myeloma (MM) not achieving complete remission (CR) or near-CR with a first autologous transplant. Results from a Spanish PETHEMA\/GEM study [abstract]","volume":"110","author":"Blade","year":"2007","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib688","doi-asserted-by":"crossref","first-page":"901a","DOI":"10.1182\/blood.V108.11.3158.3158","article-title":"Unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with high risk multiple myeloma [abstract]","volume":"108","author":"Sorasio","year":"2006","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib636","volume-title":"VI International Workshop on Multiple Myeloma","author":"Alyea","year":"1997"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib658","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20641"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib649","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)01603-0"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib689","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601186150"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib637","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701459"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib653","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)01010-X"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib667","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2387"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib671","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065464"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib647","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.04.006"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib633","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400546"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib665","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2003.50009"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib651","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2955"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib655","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703652"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib679","first-page":"179a","article-title":"Long-term follow-up of 83 patients with multiple myeloma (MM) treated on a phase I-II study of skeletal targeted radiotherapy (STR) using 166Ho-DOTMP plus melphalan with or without total body irradiation (TBI) and autologous hematopoietic stem cell transplant (AHSCT) [abstract]","volume":"100","author":"Giralt","year":"2002","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib668","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036848"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib669","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3869"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib687","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.02.003"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib627","volume-title":"Hematology","author":"Anderson","year":"2002"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib644","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5807"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib663","doi-asserted-by":"crossref","first-page":"890a","DOI":"10.1182\/blood.V110.11.3032.3032","article-title":"A non-myeloablative regimen of fludarabine and melphalan is safe and well tolerated for allogeneic transplantation in multiple myeloma [abstract]","volume":"110","author":"Qazilbash","year":"2007","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib638","doi-asserted-by":"crossref","first-page":"875a","DOI":"10.1182\/blood.V110.11.2980.2980","article-title":"Anti-thymocyte globulin induces higher response rates and less graft-versus-host disease in multiple myeloma patients undergoing allogeneic stem cell transplantation [abstract]","volume":"110","author":"Ayuk","year":"2007","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib626","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0174"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib631","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703253"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib648","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705605"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib676","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403575"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib641","first-page":"669a","article-title":"Response to donor lymphocyte infusions (DLI) of patients with CML in relapse after allografting: a long-term follow-up study using RT-PCR [abstract]","volume":"94","author":"Cwynarski","year":"1999","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib685","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705161"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib635","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib662","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-078592"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib628","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","article-title":"Graft-versus-myeloma effect: Proof of principle","volume":"87","author":"Tricot","year":"1996","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib645","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02726.x"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib654","first-page":"859a","article-title":"Non-myeloablative allogeneic transplantation as part of salvage therapy for relapse of multiple myeloma after autologous transplantation","volume":"100","author":"Hoepfner","year":"2002","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib678","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200211000-00010"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib632","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701980"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib642","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.V96.8.2712","article-title":"Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","volume":"96","author":"Dazzi","year":"2000","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib646","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701362"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib634","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702685"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib681","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05513.x"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib674","first-page":"939","article-title":"CD8 depleted donor lymphocytes for CML relapsing post BMT","volume":"23","author":"Champlin","year":"1995","journal-title":"ISEH"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib639","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2004.06.002"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib652","doi-asserted-by":"crossref","first-page":"889a","DOI":"10.1182\/blood.V110.11.3029.3029","article-title":"Long-term outcome of autologous followed by nonmyeloablative allografting from HLA-identical sibling for multiple myeloma (MM) [abstract]","volume":"110","author":"Rotta","year":"2007","journal-title":"Blood"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib657","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21700"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib675","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3250"},{"key":"9780511551901.CBO9780511551901A015_CBO9780511551901bib661","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.01.017"}],"container-title":["Treatment of Multiple Myeloma and Related Disorders"],"original-title":[],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/5D53171C7AE28D1272D1E96931DBC7C7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:02:27Z","timestamp":1655118147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9780511551901A015\/type\/book_part"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,27]]},"ISBN":["9780521515030","9780511551901"],"references-count":65,"URL":"https:\/\/doi.org\/10.1017\/cbo9780511551901.009","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1017\/cbo9780511551901","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2008,10,27]]}}}